Concepedia

Body Weight Changes with β-Blocker Use: Results from GEMINI

Franz H. Messerli, David S.H. Bell, Vivian Fonseca, Richard E. Katholi, Janet B. McGill, Robert A. Phillips, Philip Raskin, Jackson T. Wright, Sripal Bangalore, Fred Holdbrook,

The American Journal of Medicine · 2007 · 108 citations · 18 references

DOI

Concepts

References

18

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

, , +17

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

BMJ · 1998 · 1.4K citations · Full text

, , +17

Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease

Samuel Klein, Lora E. Burke, George A. Bray et al. · Circulation · 2004 · 928 citations

, , +17

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome

Ele Ferrannini, S. M. Haffner, Braxton D. Mitchell et al. · Diabetologia · 1991 · 914 citations · Full text

, , +11

Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

George L. Bakris, Vivian Fonseca, Richard E. Katholi et al. · JAMA · 2004 · 792 citations

, , +17